Reducing second breast cancers: A potential role for prophylactic mammary irradiation

Journal of Clinical Oncology

Volumn 25, Issue 31, 2007, Pages 4868-4872

  Brenner, David J ^a   Shuryak, Igor ^a   Russo, Sandra ^a   Sachs, Rainer K ^b  

^a NewYork Presbyterian Hospital   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CELL SURVIVAL; HODGKIN DISEASE; HUMAN; LUNG CANCER; LUNG SMALL CELL CANCER; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION INJURY; REVIEW; SECOND CANCER;

BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIATION DOSAGE; RADIOTHERAPY;

EID: 36849043178     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.0379     Document Type: Review

References (50)

1. NIH Consensus Conference: Treatment of early-stage breast cancer. JAMA 265:391-395, 1991
2. Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: Pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96:115-121, 2004
3. Smith TE, Lee D, Turner BC, et al: True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48:1281-1289, 2000
4. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
5. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002
6. Freedman GM, Anderson PR, Hanlon AL, et al: Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys 61:1328-1336, 2005
7. Gao X, Fisher SG, Emami B: Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study. Int J Radiat Oncol Biol Phys 56:1038-1045, 2003
8. Hankey BF, Curtis RE, Naughton MD, et al: A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst 70:797-804, 1983
9. Travis LB, Hill DA, Dores GM, et al: Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290:465-475, 2003
10. van Leeuwen FE, Klokman WJ, Stovall M, et al: Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95:971-980, 2003
11. Tinger A, Wasserman TH, Klein EE, et al: The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 37:865-870, 1997
12. Gilbert ES, Stovall M, Gospodarowicz M, et al: Lung cancer after treatment for Hodgkin's disease: Focus on radiation effects. Radiat Res 159:161-173, 2003
13. Sachs RK, Brenner DJ: Solid tumor risks after high doses of ionizing radiation. Proc Natl Acad Sci U S A 102:13040-13045, 2005
14. Shuryak I, Sachs RK, Hlatky L, et al: Radiation-induced leukemia at doses relevant to radiation therapy: Modeling mechanisms and estimating risks. J Natl Cancer Inst 98:1794-1806, 2006
15. Little MP: A multi-compartment cell repopulation model allowing for inter-compartmental migration following radiation exposure, applied to leukaemia. J Theor Biol 245:83-97, 2007
16. Haffty BG, Carter D, Flynn SD, et al: Local recurrence versus new primary: Clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. Int J Radiat Oncol Biol Phys 27:575-583, 1993
17. Schlechter BL, Yang Q, Larson PS, et al: Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. J Clin Oncol 22:1830-1838, 2004
18. Komoike Y, Akiyama F, Iino Y, et al: Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 12:104-111, 2005
19. Veronesi U, Marubini E, Del Vecchio M, et al: Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J Natl Cancer Inst 87:19-27, 1995
20. Krauss DJ, Kestin LL, Mitchell C, et al: Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys 60:731-740, 2004
21. Thompson DE, Mabuchi K, Ron E, et al: Cancer incidence in atomic bomb survivors: Part II. Solid tumors, 1958-1987. Radiat Res 137:S17-S67, 1994 (suppl 2)
22. Land CE, Gilbert E, Smith JM: Report of the NCI-CDC Working Group to Revise the 1985 NIH Radioepidemiological Tables. Bethesda, MD, National Cancer Institute, NIH publication 03-5387, 2003. http://www.irep.nci.nih.gov
23. Nuclear Regulatory Commission: Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII. Washington, DC, The National Academies Press, 2005
24. National Cancer Institute: Draft report of the NCI-CDC working group to revise the 1985 NIH radioepidemiological tables. Bethesda, MD, National Cancer Institute, 2002. http://dceg.cancer.gov/files/NIH_No_03-5387.pdf
25. National Cancer Institute: Probability of Developing or Dying of Cancer Software, Version 6.1.0. Bethesda, MD, Statistical Research and Applications Branch, National Cancer Institute, 2006
26. Arias E: United States life tables, 2003. Natl Vital Stat Rep 54:1-40, 2006
27. Brenner H: Long-term survival rates of cancer patients achieved by the end of the 20th century: A period analysis. Lancet 360:1131-1135, 2002
28. Storm HH, Andersson M, Boice JD Jr, et al: Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst 84:1245-1250, 1992
29. Unnithan J, Macklis RM: Contralateral breast cancer risk. Radiother Oncol 60:239-246, 2001
30. Boice JD Jr, Harvey EB, Blettner M, et al: Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326:781-785, 1992
31. Harvey EB, Brinton LA: Second cancer following cancer of the breast in Connecticut, 1935-82. Natl Cancer Inst Monogr 68:99-112, 1985
32. Wallner P, Arthur D, Bartelink H, et al: Workshop on partial breast irradiation: State of the art and the science, Bethesda, MD, December 8-10, 2002. J Natl Cancer Inst 96:175-184, 2004
33. Formenti SC: External-beam partial-breast irradiation. Semin Radiat Oncol 15:92-99, 2005
34. Weed DW, Edmundson GK, Vicini FA, et al: Accelerated partial breast irradiation: A dosimetric comparison of three different techniques. Brachytherapy 4:121-129, 2005
35. Vicini F, Winter K, Straube W, et al: A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: Initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319. Int J Radiat Oncol Biol Phys 63:1531-1537, 2005
36. NSABP B-39, RTOG 0413: A randomized phase III study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. Clin Adv Hematol Oncol 4:719-721, 2006
37. Lester JF, MacBeth FR, Coles B: Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: A Cochrane Review. Int J Radiat Oncol Biol Phys 63:690-694, 2005
38. Scutt D, Manning JT, Whitehouse GH, et al: The relationship between breast asymmetry, breast size and the occurrence of breast cancer. Br J Radiol 70:1017-1021, 1997
39. Leith JT, Hercbergs AA: Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst 86:393-394, 1994
40. Stingl J, Eirew P, Ricketson I, et al: Purification and unique properties of mammary epithelial stem cells. Nature 439:993-997, 2006
41. Paguirigan A, Beebe DJ, Liu B, et al: Mammary stem and progenitor cells: Tumour precursors? Eur J Cancer 42:1225-1236, 2006
42. Telang NT, Bradlow HL, Osborne MP: Effect of tamoxifen on mammary preneoplasia: Relevance to chemopreventive intervention. Cancer Detect Prev 18:313-321, 1994
43. Phillips TM, McBride WH, Pajonk F: The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98:1777-1785, 2006
44. Turesson I, Thames HD: Repair capacity and kinetics of human skin during fractionated radiotherapy: Erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up. Radiother Oncol 15:169-188, 1989
45. Muren LP, Maurstad G, Hafslund R, et al: Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother Oncol 62:173-183, 2002
46. Alpers CE, Wellings SR: The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 16:796-807, 1985
47. Suwinski R, Lee SP, Withers HR: Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys 40:797-806, 1998
48. Petersen PM, Giwercman A, Daugaard G, et al: Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol 20:1537-1543, 2002
49. Broeks A, Braaf LM, Huseinovic A, et al: Identification of women with an increased risk of developing radiation-induced breast cancer: A case only study. Breast Cancer Res 9:R26, 2007. http://breast-cancer-research.com/content/9/2/ R26
50. Goldfrank D, Chuai S, Bernstein JL, et al: Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiol Biomarkers Prev 15:2311-2313, 2006